Deformable Vesicles with Edge Activators for the Transdermal Delivery of Non-Psychoactive Cannabinoids.
Elisa VettoratoMarisa FiordelisiSilvia FerroDesirè ZaninErica FranceschinisGiovanni MarzaroNicola RealdonPublished in: Current pharmaceutical design (2024)
Desoxy-cannabidiol was successfully produced at high yields, and formulated into transethosomes optimized for transdermal delivery. Loaded vesicles showed improved skin penetration of desoxy-cannabidiol, cannabidiol and a lipophilic probe. These results suggest the potential of these carriers for the transdermal delivery of highly lipophilic drugs.